STEGGERDA, SUSANNE M.,MACKINNON, ANDREW L.,RODRIGUEZ, MIRNA L.,ZHANG, DONG,PARLATI, FRANCESCO
申请号:
CA2952213
公开号:
CA2952213A1
申请日:
2015.06.12
申请国别(地区):
CA
年份:
2015
代理人:
摘要:
The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an anticancer agent such as an enzyme inhibitor (such as a kinase inhibitor), a mitotic inhibitor, a DNA-modifying agent, or a cytidine analog. The invention further relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases that are resistant to one or more anticancer agents.